Cargando…
Immunophenotype of a Rat Model of Duchenne's Disease and Demonstration of Improved Muscle Strength After Anti-CD45RC Antibody Treatment
Corticosteroids (CS) are standard therapy for the treatment of Duchenne's muscular dystrophy (DMD). Even though they decrease inflammation, they have limited efficacy and are associated with significant side effects. There is therefore the need for new protolerogenic treatments to replace CS. D...
Autores principales: | Ouisse, Laure-Hélène, Remy, Séverine, Lafoux, Aude, Larcher, Thibaut, Tesson, Laurent, Chenouard, Vanessa, Guillonneau, Carole, Brusselle, Lucas, Vimond, Nadège, Rouger, Karl, Péréon, Yann, Chenouard, Alexis, Gras-Le Guen, Christèle, Braudeau, Cécile, Josien, Régis, Huchet, Corinne, Anegon, Ignacio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746111/ https://www.ncbi.nlm.nih.gov/pubmed/31552055 http://dx.doi.org/10.3389/fimmu.2019.02131 |
Ejemplares similares
-
Advances in Genome Editing and Application to the Generation of Genetically Modified Rat Models
por: Chenouard, Vanessa, et al.
Publicado: (2021) -
CD4(+) and CD8(+) regulatory T cell characterization in the rat using a unique transgenic Foxp3-EGFP model
por: Ménoret, Séverine, et al.
Publicado: (2023) -
Comparative Analysis of piggyBac, CRISPR/Cas9 and TALEN Mediated BAC Transgenesis in the Zygote for the Generation of Humanized SIRPA Rats
por: Jung, Chris J., et al.
Publicado: (2016) -
Characterization of Dystrophin Deficient Rats: A New Model for Duchenne Muscular Dystrophy
por: Larcher, Thibaut, et al.
Publicado: (2014) -
In Vivo Analysis of Human Immune Responses in Immunodeficient Rats
por: Ménoret, Séverine, et al.
Publicado: (2020)